- 9-ING-41Combined With Chemotherapy in Adolescents and Adults
- A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma
- A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
- A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
- A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma
- A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma
- A Study of PRT2527 in Patients With Advanced Solid Tumors
- A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
- A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
- Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
- Bevacizumab and Radiation Therapy for Sarcomas
- CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Solid Tumors
- CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
- Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
- Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
- Detection of Circulating Tumor Cells in Patients With Sarcomas
- DHEA in Synovial Sarcoma Patients
- Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
- Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy
- Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
- Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
- Hypofractionated Radiotherapy With Sequential Chemotherapy in Primary Unresectable or Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
- Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
- MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
- Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
- Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors
- Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
- Preoperative Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
- Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
- Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
- Sorafenib and Dacarbazine in Soft Tissue Sarcoma
- Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
- Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- SPEARHEAD-3 Pediatric Study
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
- Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients With Synovial Sarcoma
- Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
- Synovate Study for Synovial Sarcoma, Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma
- T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study
- Trial of CMB305 and Atezolizumab in Patients With Sarcoma
- Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
- Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases
Clinical Trials
- A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome
- Comparison of the Frequency of Subclinic Synovitis in the Distal Interphalangeal Joints of the Hand in Psoriasis Patients
- Computer-Assisted Quantification of the Synovial Perfusion in Patients With Arthritis Using Two-Dimensional and Three-Dimensional Power Doppler Ultrasonography
- Corticosteroid Meniscectomy Randomized Trial
- Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders
- Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
- Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee
- Embolization in Hereditary Coagulopathies
- Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children
- Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis
- Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy
- Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee
- Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
- Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
- Prospective Analgesic Compound Efficacy (PACE) Study
- Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
- The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
- A Prospective Natural History Study of Patients With Syringomyelia
- Establishing the Physiology of Syringomyelia
- Genetic Analysis of the Chiari I Malformation
- Impact of Peripheral Afferent Input on Central Neuropathic Pain
- Investigation of the Effects of Exercise on Patients With Chiari Malformation
- Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
- Study and Surgical Treatment of Syringomyelia
- (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
- (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent and Smoldering Systemic Mastocytosis
- A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002
- Adaptation of the Questionnaire “Regarding Patient’s Quality of Life With Mastocytosis” in the French Language
- Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
- Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
- Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
- Evaluation of Response of Dasatinib to Treat Mastocytosis
- Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
- Expanded Access Program (EAP) for Avapritinib in Patients With AdvSM
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
- Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer
- GTB-3550 (CD16/IL-15/CD33) Tri-Specific Killer Engager (TriKE™) for High Risk Heme Malignancies
- Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
- Imatinib in KIT-negative Systemic Mastocytosis
- Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
- Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis
- Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis
- Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
- Midostaurin in Indolent Systemic Mastocytosis
- Obatoclax for Systemic Mastocytosis
- Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
- Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
- Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
- Study of BLU-263 in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies
- Treatment of Indolent Systemic Mastocytosis With PA101
- Use of Tamoxifen in Systemic Mastocytosis
- 7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic Sclerosis
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
- A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis
- A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
- A Pilot Study to Evaluate the Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
- A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis
- A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
- A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects
- A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
- A Study in People With Systemic Sclerosis to Test Whether BI 685509 Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
- A Study of Guselkumab in Participants With Systemic Sclerosis
- A Study of KHK4827 in Patients With Systemic Sclerosis
- A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
- A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis
- A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)
- A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
- A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
- A Study to Investigate Safety of GS-248 and Efficacy on Raynauds’ Phenomenon in Systemic Sclerosis
- A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
- A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis
- A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis
- A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
- ADMSCs for the Treatment of Systemic Sclerosis
- AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis
- Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
- Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
- An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)
- An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)
- An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
- Analysis of Cytokine Expression Pattern in Systemic Sclerosis
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients
- Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis
- Antioxidant Profile in Patients With Systemic Sclerosis and Periodontitis
- Apollo Device for Fatigue in Systemic Sclerosis
- Assessment of Nutritional Status in Systemic Sclerosis
- Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
- Auto-immunity and Pulmonary Arterial Hypertension
- Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers
- Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
- Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
- BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA
- Bosentan in Systemic Sclerosis
- Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
- Brentuximab Vedotin for Systemic Sclerosis
- Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis
- Calcinosis Reduction by Pyrophosphate in SSC
- Cardiac Repercussion of Systemic Sclerodermias
- Cardiac Safe Transplants for Systemic Sclerosis
- Cell Surface Marker Expression in Autoimmune Diseases
- Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
- Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma – Pilot Study
- Clinical Study of Divozilimab in Patients With Systemic Scleroderma
- Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease
- CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
- Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
- Cold Challenge With C21 in RP
- Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
- Conception of an ICF Core Set for Systemic Sclerosis
- Connective Tissue Diseases and Lung Manifestations
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
- COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
- CSL Behring Sclero XIII
- Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease
- Deployment o the Multidisciplinary Prospective Cohort Imminent
- Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.
- Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
- Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis
- Development and Prevention of Severe Heart Disease in Systemic Sclerosis
- Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
- Digital Ulceration
- Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
- Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
- Duke Scleroderma Clinic Patient Registry
- Early Therapy of Pulmonary Arterial Hypertension
- Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
- Echo Systemic Sclerosis
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
- Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis
- Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc
- Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension
- Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis
- Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis
- Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
- Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis
- Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
- Effectiveness of Cannabinoids on Appetite in Scleroderma
- Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis
- Effectiveness of Telerehabilitation on Scleroderma
- Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
- Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
- Effects of a Supervised Exercise Program and a Home Exercise Program in Patients With Systemic Sclerosis
- Effects of FT011 in Systemic Sclerosis
- Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis – a Pilot Study
- Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis
- EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
- Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis
- Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)
- Efficacy and Safety of Imatinib in Scleroderma
- Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease
- Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
- Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH
- Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
- Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis
- Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
- Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension
- Evaluate Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) Transplantation in Systemic Sclerosis
- Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease
- Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
- Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis
- Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
- Evaluation of Calcinosis in Systemic Sclerosis
- Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients
- Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
- Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis
- Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program
- Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
- Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Exercise in People With Systemic Sclerosis
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
- Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis
- FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC
- Frequency of Fibromyalgia Syndrome in Patients With Systemic Sclerosis
- Fresolimumab In Systemic Sclerosis
- Functional Exercise Tests in Patients With Systemic Sclerosis
- Gastroesophageal Reflux Treatment in Scleroderma
- Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis
- Gut Microbiota Transplantation in Systemic Sclerosis
- Health-related Quality of Life in Korean Patients With Rheumatic Diseases
- Hemodynamic Changes in Connective Tissue Disease
- Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD
- Idiopathic Pulmonary Fibrosis–Pathogenesis and Staging – SCOR in Occupational and Immunological Lung Diseases
- IgG-4 Levels in Systemic Sclerosis
- Iguratimod in Systemic Sclerosis
- IL1-TRAP, Rilonacept, in Systemic Sclerosis
- ILD-SARDs Registry and Biorepository
- Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
- Imatinib in Systemic Sclerosis
- Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
- Immunoadsorption in Patients With Severe Systemic Sclerosis
- Immunomodulating Effects of Supplementation With 25-OH Vitamin D
- Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of Test
- Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis
- Implementation of a Biological Sample Collection in Systemic Sclerosis Patients
- Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
- Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.
- Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
- Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis
- Intraoperative ICG for Systemic Sclerosis
- Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis
- Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?
- Itch and Clinacal Caracteristics in Systemic Sclerosis
- IVIG Treatment in Systemic Sclerosis
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis
- Klotho and Mineral Bone Density in Systemic Sclerosis
- Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
- Light Treatment for Scleroderma Finger Ulcers
- Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc)
- Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
- Longitudinal Spatial Frequency Domain Imaging Study
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
- Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement
- Lower Urinary Tract Symptoms in Systemic Sclerosis
- Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis
- Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
- Meir Medical Center Rheumatologic Biobank
- Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
- Microparticles’s Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
- microRNAs in Systemic Scleroderma
- Mouth Handicap in Systemic Sclerosis Questionnaire (MHISS) in Turkish
- MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
- Muscular Respiratory Involvement and Systemic Sclerosis
- Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)
- Mycophenolate Mofetil in Systemic Sclerosis
- Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
- Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis
- Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis
- Neutrophil Extracellular Traps in Systemic Sclerosis
- New Orleans Pulmonary Hypertension Biobank
- Nilotinib in the Treatment of Systemic Sclerosis
- Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis
- Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer
- Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis
- Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
- Novel Splinting Technique Using 3D Models
- Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome
- Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
- Online Fatigue Intervention Program for People With Scleroderma
- Open Label Extension Study of Brentuximab Vedotin in Early dcSSc
- Open-Label Study of Oral Treprostinil in Digital Ulcers
- Optical Coherence Tomography Imaging in Systemic Sclerosis
- Oral Health and People With Systemic Sclerosis
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
- Oral Manifestations of Systemic Sclerosis
- Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
- Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease
- PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 9
- Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
- Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD)
- Phase 3 Study of MT-0551 in Patients With Systemic Sclerosis
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
- Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud’s Phenomenon Secondary to Systemic Sclerosis
- Phenotyping of Chronic Pain in Diffused Systemic Scleroderma
- Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
- Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
- Placebo Controlled Trial of Bosentan in Scleroderma Patients
- Plasmacytoid Dendritic Cells and Toll Like Receptor 8 in Systemic Sclerosis
- Platelet Gel in Systemic Sclerosis
- Pragmatic Clinical Trials in Scleroderma
- Prednisolone in Early Diffuse Systemic Sclerosis
- Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis
- Prevention and Treatment of Digital Ulcers in Systemic Sclerosis
- Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
- Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition
- Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
- Proof of Biological Activity of SAR100842 in Systemic Sclerosis
- Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
- Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis
- Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking.
- Psychological Treatments for Scleroderma
- Pulmonary Arterial Hypertension in Systemic Sclerosis
- Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)
- Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
- Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis
- Rapamycin vs Methotrexate in Diffuse SSc
- Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma
- Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
- Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis
- Rehabilitation Program in Patients With Scleroderma
- RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)
- Rheopheresis for Raynaud’s and Digital Ulcers in Systemic Sclerosis
- RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
- Rituximab in Systemic Sclerosis
- Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis
- Role of Eosinophil in Fibrogenesis of Systemic Sclerosis
- Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
- Sacroiliitis in Systemic Sclerosis
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
- Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
- Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)
- Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
- Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis
- Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis
- Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
- Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
- SCLERoderma et Adipose-DErived Stroma Cells
- Scleroderma Lung Disease
- Scleroderma Lung Study III – Combining Pirfenidone With Mycophenolate
- Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
- Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
- Scleroderma Registry
- Scleroderma Treatment With Autologous Transplant (STAT) Study
- Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
- Scleroderma: Cyclophosphamide or Transplantation (SCOT)
- Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
- SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
- Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies
- Seoul National University Hospital Systemic Sclerosis Cohort
- Serial Night Time Position Splint on Systemic Sclerosis
- Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
- Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
- Sleep Quality, Stress, Depression, Blood Pressure Responses to Diaphragmatic Respiratory Exercise in Systemic Sclerosis
- Small Bowel Motility in Patients With Systemic Sclerosis
- Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up
- Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule Endoscopy
- Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
- SPIN Self-Management Feasibility Trial
- SPIN Self-Management Full-Scale Trial (SPIN-SELF)
- Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
- Stem Cell Transplant to Treat Patients With Systemic Sclerosis
- Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
- Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
- Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging Study
- Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
- Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease
- Study of Silicone-Associated Connective Tissue Diseases
- Study of the Intestinal Microbiota of Patients With Systemic Sclerosis
- Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease
- Study to Evaluate Efficacy, Safety, and Tolerability of MT‑7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
- Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
- Subcutaneous Injections of Autologous ASC to Heal Digital Ulcers in Patients With Scleroderma.
- Suction Based Characterization of Healthy and Diseased Skin
- Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis
- Systemic Sclerosis and Innate T Cells
- Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages
- Systemic Sclerosis Clinical and Biomarker Study
- Systemic Sclerosis’ Relatives Reflex
- Telerehabilitation Approach on Individuals With Hand-Affected Scleroderma
- Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
- The Benefit of Bermekimab in Patients With Systemic Sclerosis
- The CARRA Registry
- The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
- The Effect of a Home-based Orofacial Exercise Program on Oral Aperture of Systemic Sclerosis Patients
- The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic Sclerosis
- The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
- The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis
- The Effect of Physiotherapy Program in Scleroderma Patients
- The Effects of Exercise in Patients With Systemic Sclerosis
- The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis
- The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
- The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
- The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility Trial
- The Small Intestine Bacterial Overgrowth Study Pilot
- The SPIN – Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)
- Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud
- Topical Rosemary Oil Application in Systemic Sclerosis
- Total Body Irradiation Using Intensity Modulated Radiation Therapy and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
- Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
- Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
- Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
- Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells
- Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
- Trial of IC351 in Female Scleroderma Patients With Raynaud’s and Sexual Dysfunction
- Trial of Topical C-82 in Systemic Sclerosis – A Phase I/II Biomarker and Safety Trial
- Trial on Outpatients With Systemic Sclerosis Treated With Well-Being Therapy or With a Control Therapy
- Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
- Trichoscopy and Systemic Scleroderma
- Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
- Upper Extremity Home Exercises in Patients With Scleroderma
- Utility of Breath-holding Test in Systemic Sclerosis
- Vasculopathy, Inflammation and Systemic Sclerosis
- Vocal Intervention in Systemic Sclerosis
- Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)
- What is the Optimal Follow-up for Patients With Systemic Sclerosis?
- A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma
- A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
- A Multicenter Clinical Trial of Daratumumab in Combination With Gemcitabine, Dexamethasone and Cisplatin in Patients With Relapsed/Refractory CD38 Positive PTCL-NOS, Angioimmunoblastic T-cell Lymphoma AITL and Other Nodal Lymphomas of T Follicular Helper Cells Origin
- A Phase 1, Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
- A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin’s Lymphoma
- A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
- A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (
- A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
- A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
- A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies
- A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL
- A Study for Patients With Non-Hodgkin’s Lymphomas
- A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma
- A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients
- A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
- Allo-HSCT as First-line Consolidation in High-risk PTCL
- AMG 319 Lymphoid Malignancy FIH
- An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
- Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies
- Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
- Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma
- Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma
- Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma
- CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.
- CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
- CD4CAR for CD4+ Leukemia and Lymphoma
- CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas
- CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
- Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
- Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas
- ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
- Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
- Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma
- Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
- Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma
- Gemcitabine in NK/T Cell Lymphoma
- Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma
- High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
- HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
- Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma
- Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
- LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma
- LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma
- Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas
- Long-term Follow-up of Patients Treated With Autologous T Cells Genetically Modified
- Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
- Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)
- p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
- Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
- PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma
- PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies
- PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell Lymphoma
- Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
- Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
- Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma
- Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies
- Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
- Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas
- Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
- Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
- Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
- Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)
- T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
- Tandem Auto-Allo Transplant for Lymphoma
- Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Trial of Endostar Combined With CHOPT for T Cell Lymphoma
- Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma
- A Pilot Study in Severe Patients With Takayasu Arteritis.
- A Registry Study on Biomarkers of Takayasu’s Arteritis (ARSBTA)
- A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
- Aerobic Capacity and Strength Exercise in Takayasu’s Arteritis
- Anti-inflammatory Treatment for Inactive Takayasu Arteritis
- China Takayasu Arteritis Registry (CTA Registry)
- Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
- Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
- Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu’s Arteritis
- Comparison of Tofacitinib and Methotrexate in Takayasu’s Arteritis
- Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu’s Arteritis
- Determining Disease Activity Biomarkers in Individuals With Takayasu’s Arteritis
- Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis
- Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
- Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
- Exercise in Juvenile Takayasu Disease
- Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
- Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis
- Infliximab Biosimilar in Takayasu’s Arteritis
- Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
- Pulmonary Artery Involvement in Takayasu’s Arteritis
- Registration Study of Takayasu’s Arteritis in China
- Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging
- Takayasu Arteritis Clinical Trial in China
- The Registry Study of Takayasu Arteritis in East China
- Use of MRI and PET for Assessing Disease Activity in Takayasu’s Arteritis
- Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome
- Autonomic Modulation in Takotsubo Syndrome
- BROKEN-SWEDEHEART-Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome
- French Observatory Syndromes Tako-Tsubo
- Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops
- Polish Registry of Takotsubo Syndrome
- Predicting the Development of Myocardial Depression in Acute Neurological Patients
- Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome
- Takotsubo Syndrome and Air Pollution
- The GErman Italian Spanish Takotsubo (GEIST) Registry
- Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children
- Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children
- High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women
- Mendelian Reverse Cholesterol Transport Study
- Quantitative Genetic Analysis of Lipid Research Clinic Family Data
- A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
- A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
- Addressing Involuntary Movements in Tardive Dyskinesia
- Aim to Reduce Movements in Tardive Dyskinesia
- D-Serine Treatment For Tardive Dyskinesia
- Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia
- Dysport for the Treatment of OMD
- Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia
- Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
- Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
- Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
- Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
- Extract of Ginkgo Biloba and Tardive Dyskinesia
- Levetiracetam Treatment of Tardive Dyskinesia
- Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
- NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
- NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
- NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
- Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
- Piracetam for Treatment Tardive Dyskinesia
- Pyridoxal Kinase Activity in Tardive Dyskinesia
- Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
- Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
- Reducing Involuntary Movements in Tardive Dyskinesia
- Reduction of Demoralization After Treatment of TD With Valbenazine
- Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.
- Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
- Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
- Safety and Efficacy of Pyridoxal 5′ -Phosphate in the Treatment of Tardive Dyskinesia
- Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
- Tardive Dyskinesia and Cognitive Function
- The Assessment of Movement Disorders Utilizing Live Two-Way Video
- The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
- Treatment of Tardive Dyskinesia With Galantamine
- Validation of the Implantation of a New Electrode for the Treatment of Dystonia
- Xenazine in Late Dyskinetic Syndrome With Neuroleptics
- A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease
- A Natural History Study of the Gangliosidoses
- Diagnostic and Screening Study of Genetic Disorders
- Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.
- Gene Therapy for Tay-Sachs Disease
- GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
- Longitudinal Study of Neurodegenerative Disorders
- N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease)
- Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2
- Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)
- Registry Gangliosidoses
- Synergistic Enteral Regimen for Treatment of the Gangliosidoses
- Aetiology of TemporaL Arteritis Study
- Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
- Diagnostic Study of Temporal Arteritis
- MRI Superficial Temporal Artery
- Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
- Ustekinumab for the Treatment of Giant Cell Arteritis